Sound waves vs. prostate cancer: new procedure aims to destroy tumors without surgery
NCT ID NCT05438563
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 30 times
Summary
This trial tests a procedure called MRI-guided TULSA for men with low to intermediate grade prostate cancer. It uses high-energy sound waves guided by MRI to precisely heat and destroy tumor cells. The goal is to control the cancer while avoiding surgery and preserving quality of life, such as urinary continence and sexual function. About 100 men aged 45 to 80 with early-stage prostate cancer will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE I PROSTATE CANCER AJCC V8 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MRI-guided transurethral ultrasound ablation (TULSA)
What this could lead to
If successful, this could offer a less invasive treatment option for prostate cancer that avoids surgery and reduces side effects like incontinence and impotence.
What could go wrong
This is an early-stage trial with only 100 participants. The procedure may not control the cancer long-term, and some men may still need additional treatments.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.